A new test could reveal how radiation affects the liver
NCT ID NCT06899152
First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time
Summary
This pilot study explores whether a combination of advanced MRI scans and a blood test called HepQuant DuO can measure liver function in people receiving radiation therapy for liver cancer. The study will enroll about 40 adults with liver cancer or liver metastases. The goal is to see if these tests are feasible and can detect changes in liver health before and after radiation, which could help guide future treatment decisions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- HepQuant DuO diagnostic test and multiparametric MRI scans
- What this could lead to
- If successful, this could lead to a non-invasive way to monitor liver health during radiation therapy, potentially helping doctors tailor treatment to protect liver function.
- What could go wrong
- This is a small pilot study focused on feasibility, not effectiveness. The tests may not reliably reflect liver function or may not be practical in routine care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOLANGIOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Montefiore Medical Center
RECRUITINGThe Bronx, New York, 10467, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- Could a vaccine help fight Hard-to-Treat cancers?
- Could a tailored diet before surgery boost liver cancer recovery?
- Can a new PET tracer light up hidden cancers?
- Can an immunotherapy drug keep liver cancer at bay after surgery?
- A new clue in the fight against colorectal cancer recurrence?